Future Prospects for Luteinizing Hormone-Releasing Hormone Analogues in Prostate Cancer Treatment

Publisher： Karger

E-ISSN： 1423-0313|85|2|110-120

ISSN： 0031-7012

Source： Pharmacology, Vol.85, Iss.2, 2010-02, pp. : 110-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment

By Guérin Olivier   Fischel Jean Louis   Ferrero Jean-Marc   Bozec Alexandre   Milano Gerard  

Pharmaceuticals, Vol. 3, Iss. 7, 2010-07 ,pp. : 2238-2247

MDPI

Access to resources Recommend Favorite

Enhanced Anti-Tumoral Activity of Methotrexate-Human Serum Albumin Conjugated Nanoparticles by Targeting with Luteinizing Hormone-Releasing Hormone (LHRH) Peptide

By Taheri Azade   Dinarvand Rassoul   Atyabi Fatemeh   Ahadi Fatemeh   Nouri Farank Salman   Ghahremani Mohammad Hossein   Ostad Seyed Nasser   Borougeni Atefeh Taheri   Mansoori Pooria  

International Journal of Molecular Sciences, Vol. 12, Iss. 7, 2011-07 ,pp. : 4591-4608

MDPI

Access to resources Recommend Favorite

In vivo Evidence of γ-Tocotrienol as a Chemosensitizer in the Treatment of Hormone-Refractory Prostate Cancer

By  

Pharmacology, Vol. 85, Iss. 4, 2010-04 ,pp. : 248-258

Karger

Access to resources Recommend Favorite

Octreotide in the Management of Hormone-Refractory Prostate Cancer

By  

Chemotherapy, Vol. 47, Iss. 2, 2001-03 ,pp. : 109-126

Karger

Access to resources Recommend Favorite

Treatment with Buserelin, an Agonist of Gonadotropin-Releasing Hormone, Suppresses Ovarian Hyperstimulation Syndrome Induced in Rabbits

By  

Pharmacology, Vol. 72, Iss. 3, 2004-10 ,pp. : 184-189

Karger

Access to resources Recommend Favorite